• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Astrazeneca Pharma India Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 39.0
  • ISIN : INE203A01020
6,345.00 54 (0.85%)
  • As on 03 Nov 2026 (EOD)

  • Today’s Low

    6,294.00

  • Today’s High

    6,373.50

  • Open

    6,373.50

  • Perv Close

    6,291.50

  • 52W Low

    5,640.00

  • 52W High

    9,849.50

Key Indicators

  • P/E(TTM)

    91.38

  • Mar.Cap (₹Cr.)

    15,862.50

  • Div & Yield %

    0.57

  • Book Value(₹)

    349.12

  • Debt-Equity Ratio

    0.85

  • AGM Date

    03-Nov-2026

  • EPS

    69.39

  • P/E Ratio

    91.38

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    15,862.50

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.00

  • BV (₹)

    349.10

  • Sales( ₹ in Cr.)

    2,275.58

  • NP (in Cr.)

    191.31

  • NP Var(%)

    9.0

  • Div%

    1800.0

  • CPS (₹)

    88.00

  • EPS (₹)

    76.50

  • Traded Value (₹ in Lakhs)

    15,708.13

  • 52 Week High

    9,849.50

  • 52 Week Low

    5,640.00

  • Price BSE

    6283.0

  • Price NSE

    6,292.00

  • Market Capital( in Cr.)

    15,708.13

  • P/C Ratio

    71.40

  • P/E Ratio

    82.10

  • Price Vs.BV

    76.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,275.58 1,716.29 1,295.53 1,002.97 805.60 813.56
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,275.58 1,716.29 1,295.53 1,002.97 805.60 813.56
Other Income 28.49 40.63 51.23 26.10 14.76 12.84
Stock Adjustments 488.37 332.94 33.77 48.86 -14.47 -2.95
Total Income 2,792.44 2,089.86 1,380.53 1,077.93 805.89 823.45
EXPENDITURE :            
Raw Materials 1,868.91 1,295.95 628.33 408.84 297.49 292.00
Power and Fuel Cost 2.88 5.30 4.87 5.54 8.10 7.37
Employee Cost 264.38 257.44 241.45 259.10 230.21 219.54
Other Manufacturing Expenses 20.71 18.45 14.38 13.79 8.05 9.11
Selling and Administration Expenses 313.46 204.87 234.33 185.72 145.09 129.72
Miscellaneous Expenses 36.83 110.04 21.49 53.95 16.01 17.40
Employee Benefit Expenses 264.38 257.44 241.45 259.10 230.21 219.54
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,507.17 1,892.05 1,144.85 926.94 704.95 675.14
Operating Profit 285.27 197.81 235.68 150.99 100.94 148.31
Interest 4.49 1.46 1.20 0.63 0.95 1.09
Gross Profit 280.78 196.35 234.48 150.36 99.99 147.22
Depreciation 28.58 39.99 14.94 16.26 16.95 20.13
Profit Before Tax 252.20 156.36 219.54 134.10 83.04 127.09
Current Tax 59.42 60.54 58.93 38.30 22.63 34.83
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 5.26 -19.92 -0.90 -3.49 -1.19 -1.04
Reported Net Profit 187.52 115.74 161.51 99.29 61.60 93.30
Extraordinary Items -3.79 -59.39 12.45 -26.96 2.05 1.58
Adjusted Net Profit 191.31 175.13 149.06 126.25 59.55 91.72
Adjustment below Net Profit -4.44 -1.17 1.00 -2.61 -1.74 3.43
P & L Balance brought forward 632.72 578.15 455.64 378.96 324.10 232.37
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 80.00 60.00 40.00 20.00 5.00 5.00
P & L Balance carried down 735.80 632.72 578.15 455.64 378.96 324.10
Dividend 0.00 0.00 0.00 0.00 5.00 5.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,800.00 1,600.00 1,200.00 800.00 500.00 100.00
Dividend Per Share(Rs) 36.00 32.00 24.00 16.00 10.00 2.00
Earnings Per Share-Unit Curr 75.01 46.30 64.60 39.72 24.64 37.32
Earnings Per Share(Adj)-Unit Curr 75.01 46.30 64.60 39.72 24.64 37.32
Book Value 349.12 308.14 284.77 235.48 204.56 182.47
Book Value(Adj)-Unit Curr 349.12 308.14 284.77 235.48 204.56 182.47

Shareholding Pattern

  • Promoter Group

    75.00%

  • Public Share Holding

    25.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 18,750,000 75.00 18,750,000 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 18,750,000 75.00 18,750,000 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 375 0.00 250 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 660,341 2.64 660,341 93
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,751,929 7.01 1,751,929 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 20,677 0.08 20,677 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,433,322 9.73 2,433,197 109
2] Non Institution
Bodies Corporate 261,446 1.05 261,446 258
Clearing Members 117 0.00 117 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 89,781 0.36 89,281 1,078
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 85,002 0.34 85,001 755
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,279,601 5.12 1,279,601 3
Individuals holding nominal share capital up to Rs. 1 lakh 1,925,521 7.70 1,818,478 28,159
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 127 0.00 127 3
Others 90,772 0.36 90,772 1
Sub Total 3,816,678 15.27 3,709,134 30,298
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 25,000,000 100.00 24,892,331 30,408

Company Background

Astrazeneca Pharma India LtdPharmaceuticals - Multinational

  • Astrazeneca Pharma India Ltd
  • BSE Code : 39.0
  • ISIN : INE203A01020

  • Incorporation Year

    1979

  • Registered Office

    Blk N1 12th Flr Manyata Embass
    Rachenahalli Outer Ring Road, Bangalore,
    Karnataka-560045

  • Telephone

    91-080-67748000

  • FAX

    91-080-67748557

  • Chairman

    Shilpa Divekar Nirula

  • Managing Director

    Praveen Rao Akkinepally

  • Company Secretary

    Tanya Sanish

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Integrated Enterprises (I) Ltd
    No. 30 Ramana Resid.,
    4th Cross Sampige Rd,Malleswaram
    Mumbai - Bangalore - 560003

Astrazeneca Pharma India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Sanofi India 3,383.25 1,857.10 1,837.40 21.38 54.17
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77